PMC:7228307 / 10336-10457 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T88","span":{"begin":30,"end":34},"obj":"Body_part"}],"attributes":[{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"derstanding the importance of cell‐based effector functions in the MOA of therapeutic mAbs requires an appreciation of Fc"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":67,"end":70},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0016702"}],"text":"derstanding the importance of cell‐based effector functions in the MOA of therapeutic mAbs requires an appreciation of Fc"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T180","span":{"begin":30,"end":34},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T181","span":{"begin":119,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"derstanding the importance of cell‐based effector functions in the MOA of therapeutic mAbs requires an appreciation of Fc"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T49","span":{"begin":41,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":"derstanding the importance of cell‐based effector functions in the MOA of therapeutic mAbs requires an appreciation of Fc"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T65","span":{"begin":30,"end":34},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T66","span":{"begin":50,"end":62},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"}],"text":"derstanding the importance of cell‐based effector functions in the MOA of therapeutic mAbs requires an appreciation of Fc"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T87","span":{"begin":30,"end":34},"obj":"Body_part"}],"attributes":[{"id":"A87","pred":"fma_id","subj":"T87","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"derstanding the importance of cell‐based effector functions in the MOA of therapeutic mAbs requires an appreciation of Fc"}